User:Mary Mendoza/Notebook/CHEM572 Exp. Biological Chemistry II/2013/02/27: Difference between revisions
From OpenWetWare
Mary Mendoza (talk | contribs) |
Mary Mendoza (talk | contribs) |
||
| Line 9: | Line 9: | ||
* The last concentration of adenosine (40 μM) for the zero point of trial 3 was run. | * The last concentration of adenosine (40 μM) for the zero point of trial 3 was run. | ||
* The acetylsalicylic acid stock solution was prepared by dissolving 13.3 mg of the white, granular solid into 492.1551 mL of 0.05 M sodium phosphate buffer at pH 7.4. | * The acetylsalicylic acid stock solution was prepared by dissolving 13.3 mg of the white, granular solid into 492.1551 mL of 0.05 M sodium phosphate buffer at pH 7.4. | ||
* The buffer | |||
<!-- ##### DO NOT edit below this line unless you know what you are doing. ##### --> | <!-- ##### DO NOT edit below this line unless you know what you are doing. ##### --> | ||
Revision as of 11:38, 27 February 2013
 Project name
|
<html><img src="/images/9/94/Report.png" border="0" /></html> Main project page <html><img src="/images/c/c3/Resultset_previous.png" border="0" /></html>Previous entry<html> </html>Next entry<html><img src="/images/5/5c/Resultset_next.png" border="0" /></html> |
ADA Kinetic Assay with the inhibitor acetylsalicylic acid
| |
